Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Forks in the road for CAR T and CAR NK cell cancer therapies
Oula K. Dagher, Avery D. Posey
Nature Immunology (2023) Vol. 24, Iss. 12, pp. 1994-2007
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Yan-Ruide Li, Ying Fang, Shaoqiang Niu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 8
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 8
The complexity of immune evasion mechanisms throughout the metastatic cascade
Nicole M. Haynes, Thomas B Chadwick, Belinda S. Parker
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1793-1808
Closed Access | Times Cited: 8
In vivo AAV–SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy
Lei Peng, Paul Renauer, Giacomo Sferruzza, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 7
Comprehensive Insights into Oral Squamous Cell Carcinoma: Diagnosis, Pathogenesis, and Therapeutic Advances
Dharshini Jagadeesan, Kathiresan V. Sathasivam, Neeraj Kumar Fuloria, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155489-155489
Closed Access | Times Cited: 7
Innate Immune Cells in Tumour Microenvironment: A New Frontier in Cancer Immunotherapy
Changhui Li, Xinyu Yu, Xinyan Han, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110750-110750
Open Access | Times Cited: 6
Electrospun nanofibers-derived functional scaffolds for cancer therapy
Gaizhen Kuang, Xiang Lin, Jinbo Li, et al.
Chemical Engineering Journal (2024) Vol. 489, pp. 151253-151253
Closed Access | Times Cited: 5
Comparison of seven CD19 CAR designs in engineering NK cells for enhancing anti‐tumour activity
Yao Wang, Jianhuan Li, Zhiqian Wang, et al.
Cell Proliferation (2024)
Open Access | Times Cited: 5
Natural killer cell-derived exosome-based cancer therapy: from biological roles to clinical significance and implications
Chaohua Si, Jianen Gao, Xu Ma
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Therapeutic effect of small extracellular vesicles from cytokine-induced memory-like natural killer cells on solid tumors
Ying‐Hong Shi, Yanxia Chen, Yi Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma
Yuxiang Huang, Hengjian Liao, Jiefu Luo, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
Xiang Wang, Wen Shen, Lan Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer
Lijuan Qin, Yuan Li, Juan Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Translational study of the regulatory mechanism by which immune synapses enhance immune cell function
Yahui Li, Xiao‐Jun Huang, Xiang‐Yu Zhao
Cancer Letters (2025) Vol. 614, pp. 217542-217542
Closed Access
Mapping the landscape of gastric cancer immunotherapy: Bibliometric insights into advances and hotspots
Zhen Yuan, Jing-Hang Wang, Hao Cui, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 3
Closed Access
Tumor Microenvironment-Responsive Nano-Immunomodulators for Enhancing Chimeric Antigen Receptor-T Cell Therapy in Lung Cancer
Qian Chen, Jie Sun, Sisi Ling, et al.
ACS Nano (2025)
Closed Access
Highlights of 2024: Cytokines and ligands modulating NK cell effector functions
Aneena Mary Shajan, Louisa Alim, Fernando Souza-Fonseca-Guimarães
Immunology and Cell Biology (2025)
Closed Access
Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses
Shaobo Yang, Michal Sheffer, Isabel E. Kaplan, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 4
Deleting SUV39H1 in CAR‐T cells epigenetically enhances the antitumor function
Yuning Wang, Zhao Guo, Shuhang Wang, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 3
Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapy
Salvatore Fiorenza, Sheryl Y.T. Lim, George S. Laszlo, et al.
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200854-200854
Open Access | Times Cited: 3
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
Xingwang Zhu, Jianxin Xue, Haifeng Jiang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
Caroline Diorio, David T. Teachey, Stephan A. Grupp
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 3
Nonpathogenic E. coli engineered to surface display cytokines as a new platform for immunotherapy
Rizwan Romee, Shaobo Yang, Michal Sheffer, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy
Minggang Fang, Alexander G. Allen, Chong Luo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top